COSMOS Pharmaceutical Corporation
3349・Prime Market・Retail Trade
COSMOS Pharmaceutical Corporation (Single Segment: Drugstore Business)
Nationwide rollout of "small trade area-type mega drugstores" offering daily consumables at low prices
| Period | Current | Previous | Change |
|---|---|---|---|
| Net Sales (Full Year) | ¥1,011,390 million | — | ↑ |
| Operating Profit (Full Year) | ¥40,404 million | — | ↑ |
| Gross Profit Margin (Full Year) | 21.1% | 19.5% | ↑ |
| Number of Stores at Period End | 1,609 stores (end of May 2025) / 1,662 stores (end of February 2026) | — | ↑ |
| Ordinary Profit to Total Assets Ratio (Full Year) | 8.6% | — | ↑ |
Business Details
Operates drugstores stocked with daily consumable goods such as Pharmaceuticals, Cosmetics, Sundries, and General Food. Adopts a high-density, small trade area-focused store opening strategy targeting a trade area population of approximately 10,000 people, centered on the "Everyday Low Price" policy and low-cost operations. Expands its store network across six regions—Kanto, Chubu, Kansai, Chugoku, Shikoku, and Kyushu—capturing consumers' thrift-oriented spending. Green Flash Co., Ltd. (a special subsidiary for employing persons with disabilities) handles comprehensive store maintenance operations.
Recent Overview
Cumulative Q3 FY2026 (ending May 2026) sales were ¥810,380 million, up 7.7% year on year, showing steady growth
For the nine-month cumulative period of the third quarter of FY2026 (ending May 2026) (June 1, 2025 to February 28, 2026), the company recorded net sales of ¥810,380 million (up 7.7% year on year), operating profit of ¥32,021 million (up 1.2% year on year), ordinary profit of ¥33,865 million (up 0.3% year on year), and quarterly net income attributable to owners of the parent of ¥22,748 million (up 1.8% year on year). During the period, 57 new stores were opened (14 in Kanto, 13 in Chubu, 11 in Kansai, 2 in Chugoku, 8 in Shikoku, 9 in Kyushu), and 4 stores were closed, bringing the total number of stores at period end to 1,662. General Food expanded to become the largest category, accounting for 63.0% of sales. The Kanto and Chubu regions drove high growth, exceeding 20% year on year. There is no change to the full-year earnings forecast (net sales of ¥1,057,000 million, operating profit of ¥40,500 million).
Key Products
Growth Drivers
- Aggressive new store opening strategy: 120 new stores opened in FY2025 (ending May 2025), with expansion into new trade areas in the Kanto and Chubu regions driving high growth
- Capturing consumers' thrift-oriented spending through the "Everyday Low Price" policy
- Improvement in gross profit margin: achieved 21.1%, up 1.6 percentage points year on year, through procurement cost reduction negotiations and price pass-through amid inflation
- Expansion of the General Food category: accounting for 61.2% of sales composition (up 6.2% year on year for the same quarter), contributing to increased visit frequency and number of items purchased
- Small trade area-type high-density store opening model: continuous multi-store expansion enabled by an abundance of candidate store locations targeting a trade area population of approximately 10,000 people
Risks
- Self-competition risk: the aggressive new store opening policy tolerates temporary declines in profitability, and the impact on existing stores from increased store density continues
- Cost increase risk: rising costs such as labor and utility expenses due to inflation are pushing up selling, general and administrative expenses (up 10.3% year on year)
- Consumption environment risk: declining consumer purchasing power due to price increases in goods and services stemming from domestic and international political instability and yen depreciation
- Intensifying competition risk: progressing oligopolization in the drugstore industry due to mass store openings, mergers, and alliances among leading companies
- Talent acquisition risk: securing and developing store operation management personnel amid accelerating multi-store expansion is explicitly stated as a management challenge
Last updated: August 28, 2025

